Awaiting development: Guidance and quality standards

Skip to filters Skip to results

Showing 301 to 301 of 301

Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter
Guidance programme: Medical technologies guidanceRemove Guidance programme: Medical technologies guidance filter
Guidance programme: Diagnostics guidanceRemove Guidance programme: Diagnostics guidance filter
Guidance programme: Public health guidelinesRemove Guidance programme: Public health guidelines filter

Guidance and quality standards awaiting development
Title	Type
Zongertinib for treating HER2-mutated unresectable or metastatic non-small-cell lung cancer [ID6573]	Technology appraisal guidance

Results per page

10
25
50
All